Regenerative Medical Technology Group Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Regenerative Medical Technology Group Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q2 2024.
  • Regenerative Medical Technology Group Inc. Debt-to-equity for the quarter ending June 30, 2024 was -111 %, a 31.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -111 +50.1 +31.1% Jun 30, 2024
Q1 2024 -117 +48.5 +29.2% Mar 31, 2024
Q4 2023 -130 +46.6 +26.4% Dec 31, 2023
Q3 2023 -143 +47.8 +25.1% Sep 30, 2023
Q2 2023 -161 +73.7 +31.4% Jun 30, 2023
Q1 2023 -166 +118 +41.6% Mar 31, 2023
Q4 2022 -177 +83.1 +32% Dec 31, 2022
Q3 2022 -191 +26.4 +12.2% Sep 30, 2022
Q2 2022 -235 -114 -95.1% Jun 30, 2022
Q1 2022 -284 -181 -177% Mar 31, 2022
Q4 2021 -260 -159 -159% Dec 31, 2021
Q3 2021 -217 -117 -117% Sep 30, 2021
Q2 2021 -120 -20.8 -20.9% Jun 30, 2021
Q1 2021 -103 -2.96 -2.97% Mar 31, 2021
Q4 2020 -100 -0.47 -0.47% Dec 31, 2020
Q3 2020 -100 +0.37 +0.37% Sep 30, 2020
Q2 2020 -99.6 Jun 30, 2020
Q1 2020 -99.7 Mar 31, 2020
Q4 2019 -100 Dec 31, 2019
Q3 2019 -100 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.